The epidemiology, inflammatory pathophysiology, diagnosis, and treatment of diabetic macular edema are discussed during Inflammatory Eye Disease Week.
Commentary|Articles|August 18, 2026
AI in ophthalmology: Retina specialists weigh the promise and the pitfalls
Author(s)Martin David Harp
AI accelerates retina trials and imaging insights, boosts screening access, and raises urgent questions on regulation, privacy, and equity.
Advertisement
Advertisement
Artificial intelligence is reshaping how retina specialists design clinical trials, screen patients, and interpret imaging, according to a collection of ophthalmologists and vision researchers who discussed the technology's expanding role—and its limitations—in eye care.
Related to this article
CLARITY program data show significantly longer time to treatment failure and higher rates of steroid-free quiescence vs placebo.
Prevent Blindness marks IED Week, October 19 to 25, as new therapies and pivotal trials reshape care for uveitis and thyroid eye disease.
Noab Banoub, a third year medical student, describes his journey into medicine and his view of ophthalmology's future.
Uveitis is uncommon, but it causes a disproportionate share of visual morbidity.
Discover how IRIS Registry real-world data turns EHR notes and images into evidence that speeds ophthalmology trials, recruitment, safety studies, and post-approval insights.
Liza M. Cohen, MD, explains when to use CT vs MRI in thyroid eye disease and why to review images yourself.
Murtaza K. Adam, MD, shares pearls on haptic docking, patient selection, and preventing complications with the Yamane technique.
Advertisement
Advertisement